Felicis Ventures Unveils Massive $900M Fund X

Funding | Jun 12, 2025 | Felicis Ventures LLC

Felicis Ventures Unveils Massive $900M Fund X

Felicis Ventures LLC has launched its largest fund to date, FV X, amounting to $900 million. The fund aims to support founders who are building transformative companies in sectors such as AI, cybersecurity, infrastructure, global resilience, and health and biotech. Felicis emphasizes its commitment to act quickly, invest with conviction, and support founders unconditionally. The firm’s portfolio includes over 50 companies valued at more than $1 billion, and more than 125 companies have been acquired or gone public. Over 70% of its active portfolio focuses on AI-native companies. Felicis champions a world-positive LP base and aims to partner with bold, visionary founders who are shaping the future with their innovative ideas.

Sectors

  • Venture Capital
  • Artificial Intelligence
  • Health and Biotech

Geography

  • United States – Felicis Ventures is based in the U.S. and focuses its investments primarily within the U.S. market, especially in sectors like AI and biotech, which are central to the tech and startup ecosystems in the country.

Industry

  • Venture Capital – The article discusses Felicis Ventures LLC, a venture capital firm, and its new fund for investing in early-stage startups.
  • Artificial Intelligence – The article emphasizes Felicis Ventures' focus on investing in AI-native companies and the transformation AI brings to the industry.
  • Health and Biotech – Felicis Ventures aims to invest in health and biotech, highlighting its potential as part of the largest components of U.S. GDP.

Financials

  • $900M – The size of Felicis Ventures' new Fund X, marking it as their largest fund to date.
  • $220B+ – The market value captured by the Felicis Ventures portfolio.

Participants

NameRoleTypeDescription
Felicis Ventures LLCVenture Capital FirmCompanyA venture capital firm based in the United States, focusing on early-stage investments in tech-driven sectors.